Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17344354rdf:typepubmed:Citationlld:pubmed
pubmed-article:17344354lifeskim:mentionsumls-concept:C0022646lld:lifeskim
pubmed-article:17344354lifeskim:mentionsumls-concept:C0007546lld:lifeskim
pubmed-article:17344354lifeskim:mentionsumls-concept:C0007560lld:lifeskim
pubmed-article:17344354lifeskim:mentionsumls-concept:C1412079lld:lifeskim
pubmed-article:17344354lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:17344354lifeskim:mentionsumls-concept:C0699493lld:lifeskim
pubmed-article:17344354pubmed:issue6lld:pubmed
pubmed-article:17344354pubmed:dateCreated2007-5-23lld:pubmed
pubmed-article:17344354pubmed:abstractTextThe purpose of the present study was to investigate the role of multidrug resistance-associated protein 4 (MRP4) in the tubular secretion of cephalosporin antibiotics. Most of the injectable cephalosporins have an inhibitory effect on the ATP-dependent uptake of [(3)H]dehydroepiandrosterone sulfate by membrane vesicles expressing hMRP4, whereas cephaloridine, cefsulodin, and cefepime do not. Aminocephalosporins have a weak inhibitory effect. Significant ATP-dependent transport of ceftizoxime (K(m), 18 microM), cefazolin (K(m), 80 microM), cefotaxime, and cefmetazole has been observed only in the membrane vesicles expressing hMRP4. Ceftizoxime and cefazolin were given by a constant intravenous infusion to wild-type and Mrp4(-/-) mice. The steady-state plasma concentrations of ceftizoxime and cefazolin were unchanged in Mrp4(-)(/)(-) mice. The urinary recovery of ceftizoxime was significantly reduced in Mrp4(-/-) mice, whereas it was unchanged for cefazolin. The kidney-to-plasma concentration ratio of ceftizoxime and cefazolin was increased 2.0- and 2.7-fold in Mrp4(-/-) mice, respectively; thus, the renal clearance with regard to the kidney concentration was reduced in Mrp4(-/-) mice, to 7.5 and 34% of the corresponding control values, respectively. These results suggest that Mrp4 is involved in the tubular secretion of ceftizoxime and cefazolin, in concert with basolateral uptake transporters.lld:pubmed
pubmed-article:17344354pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17344354pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17344354pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17344354pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17344354pubmed:languageenglld:pubmed
pubmed-article:17344354pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17344354pubmed:citationSubsetIMlld:pubmed
pubmed-article:17344354pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17344354pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17344354pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17344354pubmed:statusMEDLINElld:pubmed
pubmed-article:17344354pubmed:monthJunlld:pubmed
pubmed-article:17344354pubmed:issn0026-895Xlld:pubmed
pubmed-article:17344354pubmed:authorpubmed-author:LeN ANAlld:pubmed
pubmed-article:17344354pubmed:authorpubmed-author:SugiyamaYuich...lld:pubmed
pubmed-article:17344354pubmed:authorpubmed-author:KusuharaHiroy...lld:pubmed
pubmed-article:17344354pubmed:authorpubmed-author:AdachiMasashi...lld:pubmed
pubmed-article:17344354pubmed:authorpubmed-author:TakeuchiKenji...lld:pubmed
pubmed-article:17344354pubmed:authorpubmed-author:SchuetzJohn...lld:pubmed
pubmed-article:17344354pubmed:issnTypePrintlld:pubmed
pubmed-article:17344354pubmed:volume71lld:pubmed
pubmed-article:17344354pubmed:ownerNLMlld:pubmed
pubmed-article:17344354pubmed:authorsCompleteYlld:pubmed
pubmed-article:17344354pubmed:pagination1591-7lld:pubmed
pubmed-article:17344354pubmed:dateRevised2009-2-8lld:pubmed
pubmed-article:17344354pubmed:meshHeadingpubmed-meshheading:17344354...lld:pubmed
pubmed-article:17344354pubmed:meshHeadingpubmed-meshheading:17344354...lld:pubmed
pubmed-article:17344354pubmed:meshHeadingpubmed-meshheading:17344354...lld:pubmed
pubmed-article:17344354pubmed:meshHeadingpubmed-meshheading:17344354...lld:pubmed
pubmed-article:17344354pubmed:meshHeadingpubmed-meshheading:17344354...lld:pubmed
pubmed-article:17344354pubmed:meshHeadingpubmed-meshheading:17344354...lld:pubmed
pubmed-article:17344354pubmed:meshHeadingpubmed-meshheading:17344354...lld:pubmed
pubmed-article:17344354pubmed:meshHeadingpubmed-meshheading:17344354...lld:pubmed
pubmed-article:17344354pubmed:year2007lld:pubmed
pubmed-article:17344354pubmed:articleTitleInvolvement of MRP4 (ABCC4) in the luminal efflux of ceftizoxime and cefazolin in the kidney.lld:pubmed
pubmed-article:17344354pubmed:affiliationDepartment of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Tokyo, Japan.lld:pubmed
pubmed-article:17344354pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17344354pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17344354pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
literatureCitation:2164_173...literatureCitation:pubmedpubmed-article:17344354lld:drugbank
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17344354lld:pubmed